RESULTS
Heart weights of control and cardiomyopathic hamsters: Figure 1 shows the heart weight and left ventricular weight normalized by body weight in the 3 groups of cardiomyopathic hamsters and in normal golden hamsters. In the control group of cardiomyopathic hamsters, both heart weight and left ventricular weight were higher than in the golden hamsters. In the coenzyme Q10 group, the normalized heart weight and left ventricular weight were both lower than in the control group. However, in the digoxin group neither of these indices differed from the control group values.
Left ventricular function in control and cardiomyopathic hamsters: Indices of left ventricular function are shown in Table I . Data regarding the left ventricular function of golden hamsters at the same age are also shown. In the cardiomyopathic hamsters without drug treatment (control group), left ventricular developed pressure, +dP/dt and the -dP/dt were lower than in the golden hamsters. The time constant (T) of left ventricular isovolumic relaxation measured by the monoexponential method (TL) was longer in cardiomyopathic hamsters than that in golden hamsters, indicating impairment of ventricular relaxation in the cardiomyopathic hamsters. The time constant measured by the best fit method (TBF) was similar in cardiomyopathic hamsters and golden hamsters, but the asymptote of left ventricular relaxation was higher in cardiomyopathic hamsters.
Jpn. Heart J. January 1991 Fig. 1 . Heart weight (HW) and left ventricular weight (LVW) in relation to body weight (BW) in cardiomyopathic hamsters and golden hamsters. C=control group; DG=digoxin group; CQ10=coenzyme Q10 group; G= golden hamsters. **p<0.o1 vs. C. Left ventricular function in the 3 groups of cardiomyopathic hamsters: As shown in Table I , the left ventricular developed pressure, +dP/dt and -dP/dt were higher in the coenzyme Q10 group than in the control group. The time constant TBF was slightly shorter in the coenzyme Q10 and digoxin groups than in the control group, although TL did not differ among the 3 groups. The asymptote of left ventricular relaxation (PB) did not differ among the 3 groups.
Left ventricular systolic pressure-volume relations (Table II) myopathy groups and healthy golden hamsters are shown in Fig. 2 . These relationships were shifted to the right for the 3 groups of hamsters with cardiomyopathy, indicating depressed systolic function. The plots for the coenzyme Q10 group lay between those for the golden hamsters and the control group. Slopes of the plots and x-intercepts were not significantly different among the 4 groups. Left ventricular systolic pressure was plotted against the normalized left ventricular volume (i.e., volume divided by left ventricular weight) in Fig. 3 . Again the slopes and x-intercepts of the 4 groups did not differ significantly.
Left ventricular diastolic pressure-volume relations: Left ventricular diastolic pressure-volume relations in the 3 cardiomyopathy groups are shown in Fig. 4 . Left ventricular end-diastolic volume was significantly smaller in the coenzyme Q10 group than in the control group at each level of left ventricular end-diastolic pressure (upper panel of Fig. 4) . However, when the normalized left ventricular volume was used, the left The BIO 14.6 strain of Syrian hamsters is known to develop myocardial lesions, including myocardial necrosis, calcification and fibrosis.8) Thus, it has been intensively studied as a model of human cardiomyopathy. Forman et al9) have studied the myocardial function of cardiomyopathic hamsters using papillary muscle preparations.
They demonstrated that developed force and the maximum rate of force development (corrected by cross-sectional area) were depressed from 60 to 320 days of age. However, those experiments were not performed under physiological conditions. More recently, Wikman-Coffelt et al10) showed that left ventricular systolic pressure and dP/dt in the isolated working heart were depressed at 250 days of age Clinical implications:
The cause of dilated (congestive) cardiomyopathy in humans is still unclear and may well be multifactorial.
Coronary microvascular spasms have been suggested to be one of the causes of myocardial necrosis and subsequent heart failure in patients with dilated cardiomyopathy.23)
McMurray et al24) recently demonstrated that malondialdehyde, a marker of lipid peroxidation, showed increased levels in patients with chronic congestive heart failure due to ischemic heart disease. Although direct evidence supporting the role of reperfusion injury and free radicals in cardiomyopathy is yet to be demonstrated, coenzyme Q10 may be effective against human cardiomyopathy by attenuating reperfusion injury due to coronary microvasospasm.
